BPC-157 therapy is a precursor, modern, and safe therapy enabling treatment of effects caused by addiction to NSAIDs
Retrieved 3 September 2024
BPC-157 is a repair molecule
This poses serious health risks, including allergic reactions, infections (particularly with injectable products), or toxicity from unknown contaminants
Seiwerth, S., Milavi, M., Vukojevi, J., Gojkovic, S., Krezic, I., Vuleti, L., Pavlov, K., Petrovic, A., Sikiri, S., Vrane, H., Prtori, A., Zizek, H., Durasin, T., Dobri, I., Stareini, M., trbe, S., Kneevi, M., ola, M., Kokot, A., Sever, M., Lovri, E., krti, A., Blagaic, A., & Sikiric, P
There has been one retrospective study involving 16 patients with knee pain who were treated with BPC-157 (sometimes in combination with TB4), but its extremely limited [9]